Papaverine Hydrochloride

Quick links to important sections

Papaverine Hydrochloride

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Papaverine Hydrochloride

The identity of Papaverine Hydrochloride is defined by its role as a smooth muscle relaxant and peripheral vasodilator, acting as a prescription-only medicine. Its core purpose is to relieve involuntary muscle tension and enhance blood flow by widening blood vessels.

Property Description
Active ingredient Papaverine
Form Solution for injection, Tablets, Capsules, Suppositories
Pharmacological class Antispasmodic Agent, Peripheral Vasodilator, Phosphodiesterase Inhibitor
Common use Relief of smooth muscle spasm and associated tension
Origin Benzylisoquinoline alkaloid derived from opium, but prepared synthetically

What Type of Medicine is Papaverine Hydrochloride?

Papaverine Hydrochloride is chemically the hydrochloride salt of Papaverine, which is classified as a benzylisoquinoline alkaloid. Though historically extracted from opium, modern commercial preparation typically involves synthesis to ensure pharmaceutical purity. Crucially, Papaverine is a non-narcotic component of opium, meaning it is pharmacologically distinct from other opium alkaloids like morphine and lacks analgesic or addictive properties. Its primary mode of action is as a musculotropic agent, causing direct relaxation of smooth muscle tissue throughout the body. Papaverine's classification as a non-specific phosphodiesterase inhibitor represents its established mechanism.


Composition and Available Forms of Papaverine

The medicine is a single-entity preparation, containing only Papaverine as its active pharmaceutical ingredient. Papaverine is recognized for its ability to directly affect muscle tone and blood flow. This isoquinoline derivative is central to its therapeutic effects. This medication helps ease discomfort and improves function by acting directly on the enzymes that regulate muscle tone and blood vessel constriction. Papaverine Hydrochloride is available in several pharmaceutical preparations, including tablets and capsules for oral use, and a sterile aqueous solution typically administered via parenteral (injection) routes, offering versatility based on the required speed of action.


What is the General Purpose of Papaverine?

The general purpose of Papaverine is to reduce or stop involuntary muscle spasm and excessive tension in the smooth muscle lining of blood vessels and internal organs, a typical use scenario being the mitigation of acute vascular constriction. By achieving smooth muscle relaxation, Papaverine can help mitigate conditions characterized by high muscle tone. The resulting vasodilation, or widening of the blood vessels, is a key beneficial effect that contributes to its therapeutic application. This action helps to mitigate conditions where high muscle tone or constricted blood flow is present.

Regulatory References

  1. DrugBank

What side effects are possible with Papaverine Hydrochloride?

Possible Side Effects and Safety Information

The safety profile of Papaverine Hydrochloride is derived from official regulatory documents. Side effects are categorized by frequency and the body system affected, ranging from common, expected events to rare, serious reactions.


Adverse Reactions Scope

Adverse effects commonly affect the Gastrointestinal System (e.g., nausea, constipation, abdominal distress) and the Nervous System (e.g., headache, drowsiness, depression). Rarer events may involve the Cardiovascular System (e.g., tachycardia, hypotension, and arrhythmias).

Frequency Classification Examples of Reactions
Rare Arrhythmias, hypotension, constipation, rash, flushing, sweating
Not Known Hepatotoxicity (Hepatitis, increased liver enzymes), Cirrhosis

Serious Adverse Reactions

The label documents the risk of Hepatitis, which, in rare cases, has been reported to progress to Cirrhosis. Clinically significant reactions involving the heart include the potential for Complete Atrioventricular (AV) Heart Block and ventricular ectopic rhythms when administered intravenously, especially at high doses or too rapidly.


Safety Restrictions and Considerations

  • Contraindication: Intravenous injection is prohibited in the presence of complete AV heart block.
  • Discontinuation Trigger: The drug must be stopped immediately if signs of liver hypersensitivity appear, such as jaundice or liver tenderness, or if liver function tests become significantly altered.
  • Population Notes: Safety and effectiveness in children have not been established. For pregnant individuals, the drug is categorized as Pregnancy Category C, to be used only if clearly necessary.

Overdose and Emergency Response

The official documentation regarding Papaverine Hydrochloride overdose primarily details manifestations related to severe cardiovascular and metabolic instability. Overdose may present with signs of vasomotor instability, which include pronounced flushing, profuse sweating (diaphoresis), and a fast heart rate (sinus tachycardia). Central Nervous System (CNS) effects are also documented, often involving generalized weakness, dizziness, drowsiness, CNS depression, involuntary eye movement (nystagmus), and double vision (diplopia). Gastrointestinal effects such as nausea and vomiting may also occur.

More severe outcomes have been reported, particularly following large oral doses. These complications involve significant metabolic disturbances, including metabolic acidosis, elevated blood sugar (hyperglycemia), and low potassium (hypokalemia). Regulatory information also notes the potential for severe CNS and cardiac events, such as seizures and tachyarrhythmias, in high-dose situations.

Due to the risk of these serious manifestations, official guidance from regulatory authorities mandates that anyone who suspects an overdose seek emergency medical attention or call a poison control line immediately. No specific antidote is established for Papaverine overdose; therefore, management relies upon meticulous monitoring of vital signs and blood chemistry, along with supportive and symptomatic treatment specifically targeting convulsions and hypotension, as described in the prescribing information.

Therapeutic Uses of Papaverine Hydrochloride

What Papaverine Hydrochloride Treats: Main Uses and Benefits

Papaverine Hydrochloride may be part of symptomatic management applied in contexts where additional support for symptoms related to systemic imbalance is required. It is commonly used to help with distressing manifestations across several therapeutic domains, including conditions presenting with systemic or localized discomfort like ureteral colic, biliary colic, cerebral ischemia, and peripheral vascular disease.

Papaverine is relevant for managing symptoms that become more disruptive during flare-ups, such as symptoms related to physical discomfort (cramping) or symptoms related to systemic imbalance. Its application is applied in clinical settings that involve acute or unstable symptom patterns, particularly in conditions presenting with systemic or localized discomfort or in procedural settings like coronary artery bypass surgery to manage potential symptoms of increased muscular activity.

“It is used in situations involving certain distressing symptoms, which contributes to easing the overall symptom load associated with symptoms linked to organ-specific functional stress.”

This support contributes to easing the overall symptom load and helps patients cope more steadily with symptom fluctuations associated with conditions characterized by periods of heightened symptoms.


Quick Fact: Relief for Symptoms of Heightened Physiological Activity

Papaverine assists with maintaining functional stability during acute or disruptive episodes by providing supportive relief for symptoms related to heightened physiological activity.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Papaverine Hydrochloride?

Papaverine Hydrochloride, a medication primarily used as a vasodilator (to relax blood vessels), is generally prescribed to adults to manage conditions involving spasm of visceral organs or blood vessel constriction. Its common uses include treating spasms in the gastrointestinal tract, biliary system, or ureter, and improving blood flow in certain peripheral or cerebral vascular conditions.


Contraindications and Cautions

Papaverine Hydrochloride is not suitable for everyone. It is contraindicated (should not be used) in patients with complete atrioventricular (AV) block, as it may worsen the condition by increasing the ventricular rate. It should also be avoided in cases of known hypersensitivity to the drug.

Special caution is advised for individuals with glaucoma, as the medication may increase intraocular pressure. Patients with liver disease should be monitored closely, as the drug is metabolized in the liver. It should be used with great care in the presence of coronary artery disease or impaired cardiac function due to its potential cardiovascular effects. Pediatric use is generally not recommended unless specifically indicated and supervised by a specialist.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes specific pharmacodynamic (PD) and physical incompatibilities for Papaverine Hydrochloride. The primary restriction involves co-administration with agents that increase the risk of severe cardiac effects, known as QTc prolongation. Substances such as Bepridil, Dronedarone, and Cisapride are officially listed as contraindicated combinations due to this risk.

Documented Pharmacodynamic Interactions

Papaverine may interfere with the therapeutic effects of Levodopa, and a worsening of Parkinsonism has been reported with concurrent use. Co-administration with other CNS depressants (e.g., Morphine) may lead to synergistic or additive effects, officially described as increasing the risk of enhanced sedation. Similarly, use with other vasodilating agents (e.g., Alprostadil) is not recommended and may result in additive adverse effects like hypotension.

Other Constraints and Physical Incompatibilities

The regulatory profile includes constraints related to administration. Papaverine Hydrochloride Injection should not be added to Lactated Ringer’s Injection, as this physical mixture is documented to result in precipitation. Furthermore, the effects of Papaverine and alcohol (Ethanol) may be additive in lowering blood pressure. Co-administration with the herbal product Ginkgo is also noted in authoritative sources as potentially increasing the risk of certain side effects. Intravenous injection is formally contraindicated in patients with complete Atrioventricular (AV) heart block.

Mechanism of Action

Papaverine Hydrochloride is characterized by a direct-acting musculotropic mechanism, primarily through two synergistic pathways that result in smooth muscle relaxation.

Enzyme Inhibition: Raising Intracellular Messengers

The core mechanism involves the non-selective inhibition of Phosphodiesterase (PDE) enzymes across various tissues. By competitively blocking PDE, the molecule prevents the hydrolysis (breakdown) of key second messengers, cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), thereby increasing their intracellular concentration. The subsequent rise in these cyclic nucleotides initiates a molecular cascade that inactivates the necessary enzyme (Myosin Light Chain Kinase) associated with smooth muscle contraction.

Ion Channel Modulation and Ca^2+ Control

A supplementary mechanism involves the direct interaction with the muscle cell membrane. Papaverine acts to block voltage-dependent L-type Calcium Channels (Cav), restricting the entry of extracellular calcium ions (Ca^2+). Since a sufficient concentration of free Ca^2+ is the prerequisite trigger for contraction, this restriction, combined with the action on PDE, promotes conditions where the smooth muscle cells cannot achieve or sustain contraction. The physiological outcome is widespread vascular relaxation (vasodilation) and decreased systemic smooth muscle tone.

Dosage and Administration Information

The usage of Papaverine Hydrochloride is strictly defined by regulatory guidelines, specifying the administration route, dosage, frequency, and preparation techniques.


The medicine is administered through three primary routes: oral (using tablets or extended-release capsules), intravenous (IV) injection, and intramuscular (IM) injection. Parenteral administration is typically reserved for instances where an immediate pharmacological effect is desired.

Dosing regimens differ by form. Oral tablets are taken three to five times a day in doses ranging from 100 mg to 300 mg. Extended-release capsules are usually scheduled twice daily (every 12 hours), starting at 150 mg. The parenteral dose range is 30 mg to 120 mg and may be repeated every 3 hours as indicated.


Specific procedural rules must be followed. IV injection requires a slow administration rate over a period of 1 to 2 minutes. Oral extended-release capsules must be swallowed whole and should not be crushed or chewed to maintain their delivery characteristics. Furthermore, the medicine can be taken without regard to meals.

Official guidance includes constraints for specific populations. The safety and effectiveness in children are not established, and the IV injection route is explicitly not recommended for children under 15 years of age. These parameters collectively establish the standardized protocol for the administration of Papaverine Hydrochloride.

Recent Clinical Evidence

Research evidence / Overview of Studies for Papaverine Hydrochloride


Evidence for Vascular Spasm and Ischemic Conditions

Research has evaluated Papaverine Hydrochloride for conditions characterized by fluctuating or episodic manifestations related to constricted blood vessels. Studies included Randomized Controlled Trials (RCTs) and regulatory reviews. Researchers primarily monitored objective outcomes, such as changes in regional blood flow and vessel diameter widening documented through angiography, in adult patients with these vasospastic disorders.

The findings describe patterns observed in the studies where measurements of increased blood flow were reported following administration. Outcomes tracked were typically immediate and applied in research contexts involving fluctuating or unstable symptoms. The physiological changes described in the research were often transient, suggesting a need for further study into sustained delivery protocols.


Evidence for Visceral Muscle Spasm (Colic)

The research basis for its evaluation in contexts such as biliary and ureteral colic relies largely on historical clinical records and reviews of older clinical trials. Studies monitored how patient-reported outcomes describing perceived discomfort changed in adult patients experiencing acute, involuntary visceral spasms. The outcomes studied for this medicine focused on tracking the reduction or termination of acute muscle tension.

Some older trials reported patterns related to the monitored change in acute smooth muscle tension in affected organs. However, a key limitation is that evidence quality varies across studies, and there is a lack of contemporary, high-quality evidence (such as recent meta-analyses of modern RCTs) needed to fully characterize the medicine's role today.


Key Evidence Gaps and Areas of Uncertainty

Long-term effects are not fully established for most applications. Research data show patterns related to the observed physiological changes may be temporary. The data for certain groups remain insufficient to draw broad conclusions, and comparative evidence is lacking for many applications when research examined Papaverine against other pharmacological agents.

Key Studies & References

  1. National Institute of Health (NIH) DailyMed: Papaverine Hydrochloride Tablet Monograph

Frequently Asked Questions (FAQ)

Common questions about Papaverine Hydrochloride (FAQ)


Q: What is Papaverine Hydrochloride actually used for?

Official indications describe its use for conditions such as peripheral and cerebral ischemia associated with arterial spasm, and myocardial ischemia complicated by arrhythmias.


Q: Is Papaverine Hydrochloride a type of narcotic or opioid?

Papaverine is derived from the opium poppy, which is the source of many controlled substances. However, its chemical and functional profile means it is not typically categorized as a controlled substance in the same class as analgesic opioids.


Q: Can Papaverine Hydrochloride cause serious liver problems?

Regulatory information has noted reports of hepatic hypersensitivity, which affects the liver. This can sometimes present with jaundice, which is a yellowing of the skin or eyes, and changes in liver function tests. Official guidance indicates that the drug's use may need to be discontinued if these symptoms develop.


Q: Is Papaverine Hydrochloride safe for elderly patients to use?

The medicine is sometimes prescribed to older adults, though special consideration is given to conditions that may reduce tolerance to cold temperatures. As with all medications, pre-existing medical conditions, particularly heart disease, are a necessary consideration.


Q: Can Papaverine Hydrochloride be used by children?

Official labeling notes that the safety and effectiveness have not been established in the pediatric population.


Q: Can using Papaverine Hydrochloride cause fatigue or drowsiness?

Official reports of side effects include tiredness, drowsiness, and a general ill feeling. Patients should be aware of these possible effects when using the medication.


Q: What happens if I forget to take or miss a scheduled use of Papaverine Hydrochloride?

If a dose is missed, regulatory patient guidance typically suggests skipping the missed dose if it is almost time for the next scheduled dose, to avoid taking two doses close together.


Q: Is it normal to feel dizzy after using Papaverine Hydrochloride?

Dizziness or a spinning sensation (vertigo) is listed among the possible side effects.


Q: What are the signs of an overdose with Papaverine Hydrochloride?

Symptoms of toxicity listed in regulatory documents include nausea, vomiting, weakness, central nervous system depression, flushing, dizziness, and an abnormally fast heart rate known as sinus tachycardia.


Q: Does Papaverine Hydrochloride change heart rate?

Official descriptions of the drug's effects note that it can cause a slight increase in heart rate. It is also noted to directly affect the heart muscle by depressing conduction.


Q: How long do the effects of Papaverine Hydrochloride usually last?

Pharmacokinetic studies indicate that the medicine has a rapid onset and offset of effect. The drug's elimination half-life is estimated to be approximately 1.5 to 2 hours, which is consistent with this action.


Q: Can women who are breastfeeding use Papaverine Hydrochloride?

Official resources state that use during breastfeeding has not been fully studied and that there is a lack of available data. It is typically advised to use with caution while nursing.


Q: Can Papaverine Hydrochloride be used during pregnancy?

Official guidance states that because it is not known if the drug is harmful to a developing fetus, use is limited to situations where the prescriber has weighed the potential benefit against the potential risk.


Q: Is Papaverine Hydrochloride known by any other chemical names?

Yes, regulatory and official databases list other chemical names for the substance. One example is 6,7-DIMETHOXY-1-VERATRYLISOQUINOLINE HYDROCHLORIDE, in addition to various commercial and monograph names.


Q: Are there any specific foods or drinks to avoid when using Papaverine Hydrochloride?

General guidance states that the medicine can be taken without concern for the timing of meals. Official warnings state that combining the medicine with alcohol may increase certain side effects.


Q: What kind of monitoring is needed while taking Papaverine Hydrochloride?

Regulatory sources indicate that monitoring for signs of hepatic hypersensitivity, such as jaundice, is relevant, as development of these symptoms may lead to a discontinuation of the drug.


Q: Is Papaverine Hydrochloride often used in emergency situations?

Regulatory guidance recommends the intravenous injection route when an immediate pharmacological effect is desired. Its documented use in treating specific cardiac issues suggests it is administered in acute or urgent clinical settings.


Q: Are there different forms of Papaverine Hydrochloride available?

Yes, the drug is available in several forms. These include oral preparations such as tablets and extended-release capsules, as well as a solution intended for injection.


Q: What is Papaverine Hydrochloride made from?

Official drug descriptions identify Papaverine as an alkaloid derived from the opium poppy. Although it shares a natural origin with certain analgesic drugs, it is chemically and functionally distinct.


Q: Does Papaverine Hydrochloride affect laboratory test results?

In cases of hepatic hypersensitivity, the drug is associated with changes in laboratory test results, specifically altered liver function tests.


Q: Is Papaverine Hydrochloride typically used for acute or chronic conditions?

The indications for the drug, such as treating arterial spasm and its recommendation for use when an immediate effect is required, suggest it is often administered for acute or temporary manifestations of these conditions.

How should Papaverine Hydrochloride be stored and disposed of?

Storage and Disposal of Papaverine Hydrochloride

Papaverine Hydrochloride must be stored according to official regulatory requirements to maintain its stability. The product should be kept at controlled room temperature, typically between 20 C and 25 C (68 F to 77 F). It is essential that the medicine is protected from freezing and kept protected from light.

Handling and Safety

The medicine must be kept in its original container and stored out of the reach and sight of children at all times.

Disposal Instructions

Any unused or expired Papaverine Hydrochloride must be disposed of following local requirements. The product must not be discarded via wastewater or typical household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Papaverine Hydrochloride found in:

A-Z Index: